• Ownership

Kanya Rajangam - Insider Trading & Ownership

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco, CA
Summary
The estimated net worth of Kanya Rajangam is at least $382K dollars as of March 11, 2025. Kanya Rajangam is the Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc. and owns shares of Senti Biosciences, Inc. (SNTI) stock worth about $270K. Kanya Rajangam is the Chief Medical Officer of Nkarta, Inc. and owns shares of Nkarta, Inc. (NKTX) stock worth about $112K.
All Insider Reports
All Insider Reports

Ownership of Kanya Rajangam

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNTI Senti Biosciences, Inc. Pres. & Chief Med. & Dev. Off. $270K -$6.07K -2.2% Mar 10, 2025
NKTX Nkarta, Inc. Chief Medical Officer $112K Jan 14, 2022
TSBX Turnstone Biologics Corp. Director Jun 3, 2024

Insider Transactions Reported by Kanya Rajangam:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.